Protein 1 | Protein 2 | Combine Score |
---|---|---|
ELOVL5 | FADS2 | 0.986 |
ACSL1 | FADS2 | 0.952 |
FADS2 | SLC27A2 | 0.936 |
ACSL3 | FADS2 | 0.933 |
ACSL5 | FADS2 | 0.928 |
ACSL6 | FADS2 | 0.922 |
ACSM5 | FADS2 | 0.92 |
ACSL4 | FADS2 | 0.918 |
FADS2 | ACSBG1 | 0.916 |
ACSBG2 | FADS2 | 0.912 |
ACSM1 | FADS2 | 0.907 |
ACSM3 | FADS2 | 0.903 |
ACSM6 | FADS2 | 0.902 |
ACSM4 | FADS2 | 0.902 |
PLA2G16 | FADS2 | 0.9 |
# | 60481 (ELOVL5) | 2180 (ACSL1) | 9415 (FADS2) | 2181 (ACSL3) | 51703 (ACSL5) | 23305 (ACSL6) | 54988 (ACSM5) | 2182 (ACSL4) | 81616 (ACSBG2) | 116285 (ACSM1) | 6296 (ACSM3) | 142827 (ACSM6) | 341392 (ACSM4) | 11145 (PLA2G16) | 11001 (SLC27A2) | 23205 (ACSBG1) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60481 (ELOVL5) | 1.00 | 0.17 | 0.15 | 0.52 | 0.17 | 0.39 | 0.33 | 0.17 | 0.17 | 0.29 | 0.40 | 0.33 | 0.33 | 0.60 | 0.37 | 0.17 |
2180 (ACSL1) | 0.17 | 1.00 | 0.17 | 1.00 | 1.00 | 1.00 | 0.86 | 1.00 | 1.00 | 0.86 | 0.86 | 0.86 | 0.86 | 0.28 | 1.00 | 1.00 |
9415 (FADS2) | 0.15 | 0.17 | 1.00 | 0.17 | 0.17 | 0.17 | 0.21 | 0.17 | 0.17 | 0.21 | 0.26 | 0.21 | 0.21 | 0.25 | 0.17 | 0.17 |
2181 (ACSL3) | 0.52 | 1.00 | 0.17 | 1.00 | 1.00 | 0.67 | 0.43 | 0.58 | 0.52 | 0.47 | 0.49 | 0.43 | 0.43 | 0.45 | 0.62 | 0.59 |
51703 (ACSL5) | 0.17 | 1.00 | 0.17 | 1.00 | 1.00 | 1.00 | 0.86 | 1.00 | 1.00 | 0.86 | 0.86 | 0.86 | 0.86 | 0.28 | 1.00 | 1.00 |
23305 (ACSL6) | 0.39 | 1.00 | 0.17 | 0.67 | 1.00 | 1.00 | 0.49 | 0.67 | 0.60 | 0.51 | 0.49 | 0.49 | 0.49 | 0.35 | 0.54 | 0.71 |
54988 (ACSM5) | 0.33 | 0.86 | 0.21 | 0.43 | 0.86 | 0.49 | 1.00 | 0.68 | 0.57 | 0.93 | 0.90 | 1.00 | 1.00 | 0.35 | 0.48 | 0.64 |
2182 (ACSL4) | 0.17 | 1.00 | 0.17 | 0.58 | 1.00 | 0.67 | 0.68 | 1.00 | 0.78 | 0.68 | 0.62 | 0.68 | 0.68 | 0.23 | 0.60 | 0.90 |
81616 (ACSBG2) | 0.17 | 1.00 | 0.17 | 0.52 | 1.00 | 0.60 | 0.57 | 0.78 | 1.00 | 0.57 | 0.54 | 0.57 | 0.57 | 0.31 | 0.51 | 0.84 |
116285 (ACSM1) | 0.29 | 0.86 | 0.21 | 0.47 | 0.86 | 0.51 | 0.93 | 0.68 | 0.57 | 1.00 | 0.86 | 0.93 | 0.93 | 0.34 | 0.52 | 0.62 |
6296 (ACSM3) | 0.40 | 0.86 | 0.26 | 0.49 | 0.86 | 0.49 | 0.90 | 0.62 | 0.54 | 0.86 | 1.00 | 0.90 | 0.90 | 0.41 | 0.54 | 0.58 |
142827 (ACSM6) | 0.33 | 0.86 | 0.21 | 0.43 | 0.86 | 0.49 | 1.00 | 0.68 | 0.57 | 0.93 | 0.90 | 1.00 | 1.00 | 0.35 | 0.48 | 0.64 |
341392 (ACSM4) | 0.33 | 0.86 | 0.21 | 0.43 | 0.86 | 0.49 | 1.00 | 0.68 | 0.57 | 0.93 | 0.90 | 1.00 | 1.00 | 0.35 | 0.48 | 0.64 |
11145 (PLA2G16) | 0.60 | 0.28 | 0.25 | 0.45 | 0.28 | 0.35 | 0.35 | 0.23 | 0.31 | 0.34 | 0.41 | 0.35 | 0.35 | 1.00 | 0.38 | 0.22 |
11001 (SLC27A2) | 0.37 | 1.00 | 0.17 | 0.62 | 1.00 | 0.54 | 0.48 | 0.60 | 0.51 | 0.52 | 0.54 | 0.48 | 0.48 | 0.38 | 1.00 | 0.55 |
23205 (ACSBG1) | 0.17 | 1.00 | 0.17 | 0.59 | 1.00 | 0.71 | 0.64 | 0.90 | 0.84 | 0.62 | 0.58 | 0.64 | 0.64 | 0.22 | 0.55 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FADS2 | Toad | Heart | - | 3464 m | 33 day | downregulated | -2.836246766 | RNA-seq | Tibetan Plateau | Asiatic toad | 1 | Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - | 28673260 |
FADS2 | Toad | Liver | - | 3464 m | 33 day | downregulated | -2.913856595 | RNA-seq | Tibetan Plateau | Asiatic toad | 1 | Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - | 28673260 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT001634 | hsa-let-7b-5p | Homo sapiens | FADS2 | 9415 | Homo sapiens | pSILAC//Proteomics;Other | Functional MTI (Weak) | 18668040 |
MIRT001634 | hsa-let-7b-5p | Homo sapiens | FADS2 | 9415 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT017360 | hsa-miR-335-5p | Homo sapiens | FADS2 | 9415 | Homo sapiens | Microarray | Functional MTI (Weak) | 18185580 |
MIRT029144 | hsa-miR-26b-5p | Homo sapiens | FADS2 | 9415 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
MIRT040802 | hsa-miR-18a-3p | Homo sapiens | FADS2 | 9415 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT041155 | hsa-miR-500a-3p | Homo sapiens | FADS2 | 9415 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT042511 | hsa-miR-423-3p | Homo sapiens | FADS2 | 9415 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT042871 | hsa-miR-324-3p | Homo sapiens | FADS2 | 9415 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT440695 | hsa-miR-218-5p | Homo sapiens | FADS2 | 9415 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 23212916 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
9415 | GO:0006629 | lipid metabolic process | GOTERM_BP_DIRECT |
9415 | GO:0006636 | unsaturated fatty acid biosynthetic process | GOTERM_BP_DIRECT |
9415 | GO:0004768 | retinol dehydrogenase activity | GOTERM_MF_DIRECT |
9415 | GO:0036109 | alpha-linolenic acid metabolic process | GOTERM_BP_DIRECT |
9415 | GO:0016213 | antioxidant activity | GOTERM_MF_DIRECT |
9415 | GO:0016020 | membrane | GOTERM_CC_DIRECT |
9415 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
9415 | GO:0005789 | endoplasmic reticulum membrane | GOTERM_CC_DIRECT |
9415 | GO:0005887 | integral component of plasma membrane | GOTERM_CC_DIRECT |
9415 | GO:0043651 | linoleic acid metabolic process | GOTERM_BP_DIRECT |
9415 | GO:0055114 | oxidation-reduction process | GOTERM_BP_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
FADS2 | 9415 | Colorectal Neoplasms | C0009404 | Neoplastic Process | 0.3 | 0.627 | 0.552 | group |
FADS2 | 9415 | Colorectal Carcinoma | C0009402 | Neoplastic Process | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Hepatitis, Drug-Induced | C1262760 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Chemically-Induced Liver Toxicity | C4279912 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Lipoidosis | C0023794 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Drug-Induced Acute Liver Injury | C3658290 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Hepatitis, Toxic | C0019193 | Injury or Poisoning | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Colorectal Cancer | C1527249 | Neoplastic Process | 0.4 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Chemical and Drug Induced Liver Injury | C4277682 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Drug-Induced Liver Disease | C0860207 | Disease or Syndrome | 0.3 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.31 | 0.627 | 0.552 | disease |
FADS2 | 9415 | Bipolar Disorder | C0005586 | Mental or Behavioral Dysfunction | 0.41 | 0.627 | 0.552 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|